The study is for the diagnosis of childhood respiratory disease using cough sounds.
Analysis of the SMARTCOUGH-C study data revealed many issues in the quality of cough recordings and that many patients were treated before their coughs were recorded.
ResApp intends to continue its Australian adult programme in parallel and initiate a US adult clinical study this US winter.
|ResApp Health Ltd||RAP||$0.070||-77.42%||79,370,373|
|Jacka Resources Ltd||JKA||$0.003||-25%||22,600|
|Latin Resources Ltd||LRS||$0.004||-20%||3,423,002|
|Uranium Equities Ltd||UEQ||$0.005||-16.67%||610,000|
|Eclipse Metals Ltd||EPM||$0.005||-16.67%||150,000|
|Hastings Technology Metals Ltd||HAS||$0.160||-15.79%||284,061|
|Aruma Resources Ltd||AAJ||$0.006||-14.29%||120,000|